Zeeshan Ali Baig: AI-Designed Peptide for Rare Bleeding Disorder
Zeeshan Ali Baig, House Officer at Federal Government Polyclinic (PGMI) Islamabad, shared a post on LinkedIn about a recent article by Juan Pablo Frontroth, published in Blood Advances, adding:
“AI-designed peptide for rare bleeding disorder
AI just designed a peptide from scratch to solve a diagnostic nightmare.
Platelet-type von Willebrand disease (PT-VWD) is a rare bleeding disorder that’s frequently misdiagnosed as a similar condition.
The treatments are completely different, so misdiagnosis can make things worse.
Researchers used an algorithm to screen over 10,000 randomly generated peptides and found one (G14) that specifically targets the mutated protein causing PT-VWD.
It blocks the abnormal platelet clumping in patient samples.
This isn’t just a potential therapy.
It’s a precision diagnostic tool built by AI.”
Title: AI-generated peptides for research and clinical practice
Authors: Juan Pablo Frontroth

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 12:29Thirunavukkarasu Angappan: Antithrombin in ECMO – Two Datasets, Two Opposite Answers
-
Nov 20, 2026, 11:38Muhammad Kashif: Therapeutic Plasma Exchange – Key Concepts at a Glance
-
Nov 20, 2026, 11:33Tyler McConville: Why Hemostatic Function Matters More Than Cell Counts in Trauma and Transfusion
-
Nov 20, 2026, 11:28Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Honoured to Serve Across Five Faculty Roles at Hematocon 2026
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA